tiprankstipranks
Advertisement
Advertisement

Innovotech Lists on OTCQB as Growth-Focused Lab Platform Expands U.S. Reach

Story Highlights
  • Innovotech begins trading on the OTCQB as it broadens U.S. investor access and reinforces its position as a specialized, regulated life sciences laboratory platform.
  • Recent revenue growth, acquisitions, and infrastructure investments have expanded Innovotech’s testing capabilities and support its strategy of scalable, differentiated antimicrobial research services.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Claim 55% Off TipRanks

Innovotech ( (TSE:IOT) ) has shared an announcement.

Innovotech Inc., a Canadian life sciences technology company focused on antimicrobial and biofilm-related testing, has begun trading its common shares on the OTCQB Market in the United States under the symbol IOTCF while maintaining its TSX Venture Exchange listing. The move is intended to broaden its U.S. investor base as the company pursues growth as an integrated, ISO-certified and GMP-accredited laboratory platform serving regulated healthcare markets.

The OTCQB listing follows a year of solid operational and financial performance in 2025, driven by organic growth and the full-year contribution of its Keystone Labs acquisition. Innovotech has expanded its analytical chemistry and testing capabilities, simplified its corporate structure, strengthened its balance sheet, and invested in advanced laboratory infrastructure to remove capacity bottlenecks and support further scale.

Management highlighted that Innovotech’s differentiation rests on deep expertise in antimicrobial and biofilm testing, the ability to execute complex, custom programs, and long-standing client relationships that support higher-value contract research work. Alongside its services, the company continues to develop proprietary technologies, including its InnovoSIL antimicrobial silver platform, while evaluating additional acquisitions and expanding U.S. investor outreach to support disciplined long-term growth.

More about Innovotech

Innovotech Inc. is a diversified life sciences services and technology company specializing in applied microbiology, analytical chemistry, and regulated laboratory testing for healthcare markets. It is a recognized leader in biofilm science and antimicrobial testing, offering contract research, microbial and analytical services, and proprietary products such as the MBEC Assay platform to support medical device, pharmaceutical, and industrial product development.

Average Trading Volume: 32,228

Technical Sentiment Signal: Sell

Current Market Cap: C$9.8M

Find detailed analytics on IOT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1